Immunology of prostatic carcinoma-An overview

Philip Frost, Noel R. Rose, Byung Kil Choe

Research output: Contribution to journalArticlepeer-review

Abstract

The possibility of altering the course of prostatic cancer by immunologic means requires a clear understanding of the host-tumor relationship in this disease. Available data suggest that prostatic tumors contain both prostate-specific and tumor-specific antigens, although evidence on the latter is still debatable. Patients with prostatic cancer often show nonspecific depression of their cell-mediated immunocompetence, as do patients with many other forms of cancer. The question of whether prostatic cancers are immunogenic; that is, whether they elicit a specific immunologic response, remains unanswered.

Original languageEnglish (US)
Pages (from-to)107-113
Number of pages7
JournalSeminars in oncology
Volume3
Issue number2
StatePublished - Jun 1976

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'Immunology of prostatic carcinoma-An overview'. Together they form a unique fingerprint.

Cite this